Susana Mellor-Pita
Overview
Explore the profile of Susana Mellor-Pita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Urbistondo M, Gonzalez-Guzman A, Fernandez-Guitian R, Blanco-Valencia X, Esteban-Sampedro J, Martin-Portugues M, et al.
BMC Rheumatol
. 2025 Feb;
9(1):27.
PMID: 40011972
Background: The higher mortality rates in patients with Systemic sclerosis (SSc) are related to SSc activity, cardiovascular disease, and neoplasms, among other factors. Our objective was to assess the impact...
2.
Vazquez-Comendador J, Mateos Seirul-Lo M, Martinez-Urbistondo M, Miguel-Ontanon N, Gonzalez-Guzman A, Fernandez-Guitian R, et al.
J Clin Rheumatol
. 2025 Jan;
31(2):78-82.
PMID: 39823212
Objective: To evaluate the impact of the different types of neoplasms and lineages on Sjögren syndrome (SjS) patient mortality. Methods: Medical records review study based on the Spanish Hospital Discharge...
3.
Chero-Sandoval L, Higuera-Gomez A, Cuevas-Sierra A, de Cuevillas B, Castejon R, Martinez-Urbistondo M, et al.
Front Microbiol
. 2024 Dec;
15:1471177.
PMID: 39654674
Introduction: Metabolic disorders and autoimmune diseases elicit distinct yet interconnected manifestations of inflammation, which may be boosted by an excess of body adiposity. The purpose of this investigation was to...
4.
Chero-Sandoval L, Martinez-Urbistondo M, Cuevas-Sierra A, Higuera-Gomez A, Martin-Domenech E, Castejon R, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518437
: Metabolic inflammation (MI), long COVID (LC) and systemic lupus erythematosus (SLE) share some metabolic common manifestations and inflammatory pathophysiological similarities. Health-related quality of life (HRQoL) and metabolic age are...
5.
Chero-Sandoval L, Higuera-Gomez A, Martinez-Urbistondo M, Castejon R, Mellor-Pita S, Moreno-Torres V, et al.
Eur J Clin Invest
. 2024 Oct;
55(2):e14339.
PMID: 39468772
Background: The relationship between systemic lupus erythematosus (SLE) and low-grade metabolic inflammation (MI) with the microbiota is crucial for understanding the pathogenesis of these diseases and developing effective therapeutic interventions....
6.
Mellor-Pita S, Tutor-Ureta P, Velasco P, Plaza A, Diego I, Vazquez-Comendador J, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066233
Patients with COVID-19 may develop a hypercoagulable state due to tissue and endothelial injury, produced by an unbalanced immune response. Therefore, an increased number of thromboembolic events has been reported...
7.
Moreno-Torres V, Martinez-Urbistondo M, Vazquez-Comendador J, Mateos Seirul-Lo M, Castejon R, Huerta A, et al.
Lupus Sci Med
. 2024 Apr;
11(1).
PMID: 38631847
Objective: To evaluate the impact of the different types of neoplasms and lineages on mortality of patients with SLE. Methods: Retrospective and observational comparison of the neoplasm-related deaths in patients...
8.
Moreno-Torres V, Martinez-Urbistondo M, Duran-Del Campo P, Tutor P, Rodriguez B, Castejon R, et al.
J Transl Autoimmun
. 2024 Mar;
8:100236.
PMID: 38426202
Introduction: Patients with sarcoidosis have a lower survival rate than the general population, in part due to cardiovascular disease, infections and neoplasms. Our objective was to evaluate the impact of...
9.
Moreno-Torres V, Cabeza Martinez R, Mellor-Pita S
Med Clin (Barc)
. 2024 Feb;
162(11):555-556.
PMID: 38341330
No abstract available.
10.
Moreno-Torres V, Martinez-Urbistondo M, Gutierrez-Rojas A, Castejon R, Sanchez E, Calderon-Parra J, et al.
Lupus Sci Med
. 2022 Oct;
9(1).
PMID: 36283745
Objective: Infections are a common complication of SLE. Our objective was to evaluate their causes and impact on the survival of patients with SLE. Methods: Analysis of the admissions and...